BeyondSpring, Inc. (BYSI)
0.6386
+0.02
(+2.97%)
USD |
NASDAQ |
Sep 09, 14:06
BeyondSpring Shareholders Equity (Quarterly) : -35.57M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -35.57M |
| March 31, 2026 | -34.49M |
| December 31, 2025 | -32.16M |
| September 30, 2025 | -31.78M |
| June 30, 2025 | -30.22M |
| March 31, 2025 | -28.31M |
| December 31, 2023 | |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | 26.68M |
| September 30, 2021 | 38.33M |
| June 30, 2021 | 55.31M |
| March 31, 2021 | 72.51M |
| Date | Value |
|---|---|
| December 31, 2020 | 88.34M |
| September 30, 2020 | 24.04M |
| June 30, 2020 | 32.14M |
| March 31, 2020 | 17.69M |
| December 31, 2019 | 30.28M |
| September 30, 2019 | 20.48M |
| June 30, 2019 | -16.24M |
| March 31, 2019 | -14.84M |
| December 31, 2018 | -7.766M |
| September 30, 2018 | |
| June 30, 2018 | 19.87M |
| March 31, 2018 | 17.52M |
| December 31, 2017 | 27.08M |
| September 30, 2017 | 39.14M |
| June 30, 2017 | 48.19M |
| March 31, 2017 | 54.19M |
| December 31, 2016 | 12.15M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
| Savara, Inc. | 143.66M |
| Vericel Corp. | 370.04M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 14.61M |
| Total Liabilities (Quarterly) | 50.63M |
| Debt to Equity Ratio | -0.0048 |
| Current Ratio | 0.6976 |
| Net Debt Paydown Yield | 0.10% |